Operator of an innovative biotechnology company intended to focus on cancer treatment. The company offers a groundbreaking immunotherapy approach that utilizes gene reprogramming to transform cancer cells into immune cell types by leveraging a novel therapeutic gene cocktail and a targeted delivery system, enabling users to make effective treatments simpler and faster for patients everywhere.